Impact of the Centers for Disease Control's HIV Preexposure Prophylaxis Guidelines for Men Who Have Sex With Men in the United States
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Preexposure prophylaxis (PrEP) is effective for preventing human immunodeficiency virus (HIV) infection among men who have sex with men (MSM) within trial settings. Population impact will depend on clinical indications for PrEP initiation, coverage levels, and drug adherence. No modeling studies have estimated the impact of clinical practice guidelines for PrEP issued by the Centers for Disease Control and Prevention (CDC). METHODS: Mathematical models of HIV transmission among MSM were used to estimate the percentage of infections averted (PIA) and the number needed to treat (NNT) under behavioral indications of the CDC's PrEP guidelines. We modeled the contribution of these indications while varying treatment coverage and adherence. RESULTS: At 40% coverage of indicated MSM over the next decade, application of CDC guidelines would avert 1162 infections per 100 000 person-years, 33.0% of expected infections. The predicted NNT for the guidelines would be 25. Increasing coverage and adherence jointly raise the PIA, but reductions to the NNT were associated with better adherence only. CONCLUSIONS: Implementation of CDC PrEP guidelines would result in strong and sustained reductions in HIV incidence among MSM in the United States. The guidelines strike a good balance between epidemiological impact (PIA) and efficiency (NNT) at plausible scale-up levels. Adherence counseling could maximize public health investment in PrEP by decreasing the NNT.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevention of HIV-1 infection with early antiretroviral therapy.
Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., Hakim, J. G., Kumwenda, J., Grinsztejn, B., Pilotto, J. H. S., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105243 · Cited by 6,873
Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.
Grant, R. M., Lama, J. R., Anderson, P. L., McMahan, V., Liu, A. Y., Vargas, L., Goicochea, P., Casapía, M., Guanira-Carranza, J. V., Ramirez-Cardich, M. E., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1011205 · Cited by 5,096
McCormack, S., Dunn, D. T., Desai, M., Dolling, D. I., Gafos, M., Gilson, R., Sullivan, A. K., Clarke, A., Reeves, I., Schembri, G., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00056-2 · Cited by 1,878
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection
Molina, J.-M., Capitant, C., Spire, B., Pialoux, G., Cotte, L., Charreau, I., Tremblay, C., Le Gall, J.-M., Cua, E., Pasquet, A., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1506273 · Cited by 1,633
Toni, T., Welch, D., Strelkowa, N., Ipsen, A., & Stumpf, M. P. H. (2009) · Journal of The Royal Society Interface · doi:10.1098/rsif.2008.0172 · Cited by 1,498
Grant, R. M., Anderson, P. L., McMahan, V., Liu, A., Amico, K. R., Mehrotra, M., Hosek, S., Mosquera, C., Casapia, M., Montoya, O., et al. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70847-3 · Cited by 1,208
Condom effectiveness in reducing heterosexual HIV transmission.
Weller, S. C., & Davis-Beaty, K. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003255 · Cited by 846
Liu, A. Y., Cohen, S. E., Vittinghoff, E., Anderson, P. L., Doblecki-Lewis, S., Bacon, O., Chege, W., Postle, B. S., Matheson, T., Amico, K. R., et al. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.4683 · Cited by 602
Volk, J. E., Marcus, J. L., Phengrasamy, T., Blechinger, D., Nguyen, D. P., Follansbee, S., & Hare, C. B. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ778 · Cited by 489
A Separable Model for Dynamic Networks
Krivitsky, P. N., & Handcock, M. S. (2014) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/rssb.12014 · Cited by 484
Smith, A. J., Le, B., Finlayson, T., Oster, A. M., & DiNenno, E. A. (2010) · MMWR Morbidity and Mortality Weekly Report · Cited by 432
Zimmerman, P. A., Buckler-White, A., Alkhatib, G., Spalding, T., Kubofcik, J., Combadiere, C., Weissman, D., Cohen, O., Rubbert, A., Lam, G., et al. (1997) · Molecular Medicine · doi:10.1007/bf03401665 · Cited by 416
What Drives the US and Peruvian HIV Epidemics in Men Who Have Sex with Men (MSM)?
Goodreau, S. M., Carnegie, N. B., Vittinghoff, E., Lama, J. R., Sanchez, J., Grinsztejn, B., Koblin, B. A., Mayer, K. H., & Buchbinder, S. P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050522 · Cited by 326
Self-citationDeterminants of Per-Coital-Act HIV-1 Infectivity Among African HIV-1–Serodiscordant Couples
Hughes, J. P., Baeten, J. M., Lingappa, J. R., Magaret, A. S., Wald, A., de Bruyn, G., Kiarie, J., Inambao, M., Kilembe, W., Farquhar, C., et al. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir747 · Cited by 305
Applying a PrEP Continuum of Care for Men Who Have Sex With Men in Atlanta, Georgia
Kelley, C. F., Kahle, E., Siegler, A., Sanchez, T., del Rio, C., Sullivan, P. S., & Rosenberg, E. S. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ664 · Cited by 298
Self-citationUnraveling the divergent results of pre-exposure prophylaxis trials for HIV prevention
van der Straten, A., Van Damme, L., Haberer, J. E., & Bangsberg, D. R. (2012) · AIDS · doi:10.1097/qad.0b013e3283522272 · Cited by 297
(2010) · PubMed · Cited by 267
Paltiel, A. D., Freedberg, K. A., Scott, C. A., Schackman, B. R., Losina, E., Wang, B., Seage III, G. R., Sloan, C. E., Sax, P. E., & Walensky, R. P. (2009) · Clinical Infectious Diseases · doi:10.1086/597095 · Cited by 259
Ware, N. C., Wyatt, M. A., Haberer, J. E., Baeten, J. M., Kintu, A., Psaros, C., Safren, S., Tumwesigye, E., Celum, C. L., & Bangsberg, D. R. (2012) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31824a060b · Cited by 255
No Evidence of Sexual Risk Compensation in the iPrEx Trial of Daily Oral HIV Preexposure Prophylaxis
Marcus, J. L., Glidden, D. V., Mayer, K. H., Liu, A. Y., Buchbinder, S. P., Amico, K. R., McMahan, V., Kallas, E. G., Montoya-Herrera, O., Pilotto, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081997 · Cited by 236
Crepaz, N., Marks, G., Liau, A., Mullins, M. M., Aupont, L. W., Marshall, K. J., Jacobs, E. D., & Wolitski, R. J. (2009) · AIDS · doi:10.1097/qad.0b013e32832effae · Cited by 229
Sullivan, P. S., Rosenberg, E. S., Sanchez, T. H., Kelley, C. F., Luisi, N., Cooper, H. L., Diclemente, R. J., Wingood, G. M., Frew, P. M., Salazar, L. F., et al. (2015) · Annals of Epidemiology · doi:10.1016/j.annepidem.2015.03.006 · Cited by 215
Self-citationEpiModel : An R Package for Mathematical Modeling of Infectious Disease over Networks
Jenness, S. M., Goodreau, S. M., & Morris, M. (2018) · Journal of Statistical Software · doi:10.18637/jss.v084.i08 · Cited by 192
Self-citationAn overview of the effectiveness and efficiency of HIV prevention programs.
Holtgräve, D. R., Qualls, N., Curran, J. W., Valdiserri, R. O., Guinan, M. E., & Parra, W. C. (1995) · Europe PMC (PubMed Central) · Cited by 171
Desai, K., Sansom, S. L., Ackers, M. L., Stewart, S. R., Hall, H. I., Hu, D. J., Sanders, R., Scotton, C. R., Soorapanth, S., Boily, M.-C., et al. (2008) · AIDS · doi:10.1097/qad.0b013e32830e00f5 · Cited by 163
The new role of antiretrovirals in combination HIV prevention: a mathematical modelling analysis
Cremin, Í., Alsallaq, R. A., Dybul, M. R., Piot, P. K., Garnett, G. P., & Hallett, T. B. (2012) · AIDS · doi:10.1097/qad.0b013e32835ca2dd · Cited by 155
Buchbinder, S. P., Glidden, D. V., Liu, A. Y., McMahan, V., Guanira, J. V., Mayer, K. H., Goicochea, P., & Grant, R. M. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70025-8 · Cited by 145
Homozygous and Heterozygous CCR5-Δ32 Genotypes Are Associated With Resistance to HIV Infection
Marmor, M., Sheppard, H. W., Donnell, D., Bozeman, S., Celum, C., Buchbinder, S., Koblin, B., & Seage, G. R. (2001) · Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200108150-00009 · Cited by 123
Male circumcision for prevention of homosexual acquisition of HIV in men
Wiysonge, C. S., Kongnyuy, E. J., Shey, M., Muula, A. S., Navti, O. B., Akl, E. A., & Lo, Y.-R. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007496.pub2 · Cited by 112
Gandhi, M., Ameli, N., Bacchetti, P., Sharp, G. B., French, A. L., Young, M., Gange, S. J., Anastos, K., Holman, S., Levine, A., et al. (2005) · AIDS · doi:10.1097/01.aids.0000189866.67182.f7 · Cited by 96
Hernández-Romieu, A. C., Sullivan, P. S., Rothenberg, R., Grey, J., Luisi, N., Kelley, C. F., & Rosenberg, E. S. (2015) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000332 · Cited by 78
Self-citationChen, A., & Dowdy, D. W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108742 · Cited by 72
Evaluating the impact of prioritization of antiretroviral pre-exposure prophylaxis in New York
Kessler, J., Myers, J. E., Nucifora, K. A., Mensah, N., Toohey, C., Khademi, A., Cutler, B. H., & Braithwaite, R. S. (2014) · AIDS · doi:10.1097/qad.0000000000000460 · Cited by 69
Use of Antiretrovirals for HIV Prevention: What Do We Know and What Don’t We Know?
Baeten, J. M., & Grant, R. M. (2013) · Current HIV/AIDS Reports · doi:10.1007/s11904-013-0157-9 · Cited by 68
Ouellet, E., Durand, M., Guertin, J. R., LeLorier, J., & Tremblay, C. L. (2015) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2015/964512 · Cited by 66
Antiretroviral pre‐exposure prophylaxis implementation in the United States: a work in progress
Mayer, K. H., Hosek, S., Cohen, S. E., Liu, A., Pickett, J., Warren, M., Krakower, D., & Grant, R. M. (2015) · Journal of the International AIDS Society · doi:10.7448/ias.18.4.19980 · Cited by 62
Rosser, B. R. S., Bockting, W. O., Rugg, D. L., Robinson, B. “. E., Ross, M. W., Bauer, G. R., & Coleman, E. (2002) · AIDS Education and Prevention · doi:10.1521/aeap.14.4.59.23885 · Cited by 55
Carnegie, N. B., Goodreau, S. M., Liu, A., Vittinghoff, E., Sánchez, J., Lama, J. R., & Buchbinder, S. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000555 · Cited by 28
Self-citationCan Male Circumcision Have an Impact on the HIV Epidemic in Men Who Have Sex with Men?
Goodreau, S. M., Carnegie, N. B., Vittinghoff, E., Lama, J. R., Fuchs, J. D., Sánchez, J., & Buchbinder, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102960 · Cited by 26
Self-citation
Cited by
Siegler, A. J., Mouhanna, F., Giler, R. M., Weiss, K., Pembleton, E., Guest, J., Jones, J., Castel, A., Yeung, H., Kramer, M., et al. (2018) · Annals of Epidemiology · doi:10.1016/j.annepidem.2018.06.005 · Cited by 404
Self-citationPrEP stigma: implicit and explicit drivers of disparity
Golub, S. A. (2018) · Current HIV/AIDS Reports · doi:10.1007/s11904-018-0385-0 · Cited by 383
Jenness, S. M., Weiss, K. M., Goodreau, S. M., Gift, T., Chesson, H., Hoover, K. W., Smith, D. K., Liu, A. Y., Sullivan, P. S., & Rosenberg, E. S. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix439 · Cited by 224
Self-citation
Metadata
- Authors
- Jenness, S. M., Goodreau, S. M., Rosenberg, E., Beylerian, E. N., Hoover, K. W., Smith, D. K., & Sullivan, P.
- Venue
- Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-07-14
- Volume
- 214
- Issue
- 12
- Pages
- 1800-1807
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2464830767
- Cited by
- 195
- References
- 39
- FWCI
- 24.36
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.